A new study uncovered a genetic connection between coronary artery disease, major depression, and an increased risk for cardiomyopathy, mediated through inflammatory pathways. The study highlights that medications used for treating coronary artery disease and depression could synergistically reduce inflammation, potentially preventing cardiomyopathy.